Roberto Salgado

Roberto Salgado publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Roberto Salgado sits on this spectrum.

Roberto Salgado D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Roberto Salgado sits on this spectrum.

Overview

Best Publications

• The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

  R. Salgado;C. Denkert;S. Demaria;N. Sirtaine

  3196
  Citations

• Pan-cancer analysis of whole genomes

  Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  3090
  Citations

• Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

  S. Loi;S. Loi;S. Michiels;S. Michiels;R. Salgado;N. Sirtaine

  1433
  Citations

• Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

  Sherene Loi;Nicolas Sirtaine;Fanny Piette;Roberto Salgado

  1368
  Citations

• CD4+ follicular helper T cell infiltration predicts breast cancer survival

  Chunyan Gu-Trantien;Sherene Loi;Soizic Garaud;Carole Equeter

  1148
  Citations

• Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis

  Peter Savas;Balaji Virassamy;Chengzhong Ye;Agus Salim;Agus Salim

  1000
  Citations

• Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis

  Samra Turajlic;Samra Turajlic;Kevin Litchfield;Hang Xu;Rachel Rosenthal

  959
  Citations

• Clinical relevance of host immunity in breast cancer: from TILs to the clinic

  Peter Savas;Roberto Salgado;Carsten Denkert;Christos Sotiriou

  945
  Citations

• Neoantigen-directed immune escape in lung cancer evolution

  Rachel Rosenthal;Rachel Rosenthal;Elizabeth Larose Cadieux;Roberto Salgado;Maise Al Bakir

  937
  Citations

• Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group Part 2 TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

  Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  897
  Citations

• Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

  Sherene Loi;Damien Drubay;Sylvia Adams;Giancarlo Pruneri

  868
  Citations

• Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research

  Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  800
  Citations

• Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.

  Leonie Voorwerk;Maarten Slagter;Hugo M. Horlings;Karolina Sikorska

  724
  Citations

• RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1/PD-L1 immune checkpoint inhibitors

  Sherene Loi;Sherene Loi;Sathana Dushyanthen;Paul A. Beavis;Roberto Salgado

  653
  Citations

• Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab A Secondary Analysis of the NeoALTTO Trial

  Roberto Salgado;Carsten Denkert;Christine Campbell;Peter Savas

  648
  Citations

• The 2019 World Health Organization classification of tumours of the breast.

  Puay Hoon Tan;Ian Ellis;Kimberly Allison;Edi Brogi

  606
  Citations

• Circulating interleukin-6 predicts survival in patients with metastatic breast cancer.

  Roberto Salgado;Sara Junius;Ina Benoy;Peter Van Dam

  569
  Citations

• Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

  Douglas B. Johnson;Monica V. Estrada;Roberto Salgado;Violeta Sanchez

  506
  Citations

• Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

  Maria Vittoria Dieci;Nina Radosevic-Robin;Susan Fineberg;Gert Van den Eynden

  434
  Citations

• Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

  Y S Ju;L B Alexandrov;M Gerstung;I Martincorena

  423
  Citations